American Cell Therapies Company Selects ValGenesis VLMS to Digitize Multiple Validation Lifecycle Processes News provided by Share this article Share this article SAN FRANCISCO, Jan. 25, 2021 /PRNewswire/ -- ValGenesis Inc., a market leader in Enterprise Validation Lifecycle Management Solutions (VLMS), today announced that a U.S. based cell therapies company has selected ValGenesis VLMS – the industry's most trusted electronic validation lifecycle management system – to digitize multiple corporate validation lifecycle processes across the organization. The company develops novel allogene...